Novartis reported CHF4.54B in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alcon AG ALC:SW 326M 18M
AstraZeneca AZN:LN 1954M 415M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Fresenius FRE:GR € 882M 18M
Galapagos GLPG:NA € -64.46M 0.5M
Genmab GEN:DC DK 1171M 749M
H. Lundbeck A/S LUN:DC 643M 159M
Johnson & Johnson JNJ:US $ 8058M 282M
Lonza Group LONN:SW 496.49M 151.49M
Novartis NOVN:VX SF 4544M 120M
Novartis NVS:US $ 4544M 120M
Orion ORNBV:FH € 57.3M 13.1M
Philips PHIA:NA € 490M 33M
Recordati REC:IM € 115.24M 4.27M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M